Clarithromycin use and risk of death in patients with ischemic heart disease
Research output: Contribution to journal › Journal article › Research › peer-review
Objectives: To examine whether treatment with clarithromycin was associated with an increased risk of death in patients with preexisting ischemic heart disease (IHD). Methods: Employing nationwide registers, all patients with IHD events from 1997 to 2007 who subsequently claimed prescriptions for dual antibiotic treatment for eradication treatment were identified. The primary endpoint was all-cause mortality. Results: The study included 214,330 individuals with IHD; 5,265 (2.5 %) of these claimed prescriptions for dual antibiotics. Compared with IHD patients not undergoing eradication therapy, no increase in the risk of all-cause mortality was demonstrated (HR 1.02; 95% CI 0.84-1.23, p = 0.87) after 5 years. Conclusions: The use of clarithromycin in the setting of eradication treatment for Helicobacter pylori in patients with IHD was not associated with an increased risk of death.
Original language | English |
---|---|
Journal | Cardiology |
Volume | 116 |
Issue number | 2 |
Pages (from-to) | 89-97 |
Number of pages | 9 |
ISSN | 0008-6312 |
DOIs | |
Publication status | Published - 1 Jul 2010 |
ID: 20395185